Trial
NCT05685225
Single-Site Study of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Phase 2 Randomized Trial
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Allodynic Therapeutics, Inc
Collaborators
—
Condition
Migraine
Intervention
Stage 1: Naltrexone/Acetaminophen
Why stopped
No participants enrolled; study suspended due to recruitment challenges.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-08